[Form 4] Citizens & Northern Corporation Insider Trading Activity
Harold F. Hoose III, Executive Vice President of Citizens & Northern Corp (CZNC), reported transactions in the company's common stock. On 08/20/2025 an exempt acquisition occurred through the company's ESOP via dividend reinvestment, resulting in 221 shares acquired at $19.63, bringing Mr. Hoose's indirect beneficial ownership to 15,718 shares. Separately, 39,321 shares were disposed (form records the disposition amount). The filing was signed by an attorney-in-fact on 08/25/2025. The form indicates the transaction was intended to qualify for an affirmative defense under Rule 10b5-1 where applicable and identifies the reporting person as an officer (EXEC. VP) and director.
Harold F. Hoose III, Vicepresidente esecutivo di Citizens & Northern Corp (CZNC), ha comunicato operazioni sul titolo ordinario della società. Il 20/08/2025 si è verificato un acquisto esentato attraverso il piano ESOP della società mediante reinvestimento dei dividendi, con 221 azioni acquisite a $19,63, portando la partecipazione indiretta del Sig. Hoose a 15.718 azioni. Separatamente, sono state cedute 39.321 azioni (l'importo della cessione risulta nel modulo). La comunicazione è stata firmata per procura il 25/08/2025. Il modulo specifica che la transazione mirava a rientrare in una difesa affermativa ai sensi della Rule 10b5-1, ove applicabile, e indica la persona che effettua la segnalazione come dirigente (VICEPRESIDENTE ESECUTIVO) e amministratore.
Harold F. Hoose III, vicepresidente ejecutivo de Citizens & Northern Corp (CZNC), informó operaciones con acciones ordinarias de la compañía. El 20/08/2025 se produjo una adquisición exenta a través del ESOP de la empresa mediante el reinversión de dividendos, resultando en 221 acciones adquiridas a $19.63, elevando la propiedad indirecta del Sr. Hoose a 15.718 acciones. De forma separada, se dispusieron 39.321 acciones (el formulario registra la cantidad dispuesta). El documento fue firmado por apoderado el 25/08/2025. El formulario indica que la transacción estaba destinada a calificar para una defensa afirmativa bajo la Regla 10b5-1 cuando corresponda e identifica a la persona informante como ejecutivo (VICEPRESIDENTE EJECUTIVO) y director.
Harold F. Hoose III, Citizens & Northern Corp(CZNC)의 전무 부사장이 회사 보통주 거래를 신고했습니다. 2025년 8월 20일 배당금 재투자를 통한 회사의 ESOP 경로로 면제 취득이 이루어져 주당 $19.63에 221주를 취득했고, 이로써 Hoose 씨의 간접적 실질보유주식은 15,718주가 되었습니다. 별도로 39,321주가 처분되었습니다(서류에 처분 수량이 기재됨). 신고서는 2025년 8월 25일 대리인이 서명했습니다. 양식은 해당되는 경우 Rule 10b5-1에 따른 적극적 방어(affirmative defense) 자격을 목적으로 한 거래였음을 명시하며, 신고인을 임원(전무 부사장) 겸 이사로 표시하고 있습니다.
Harold F. Hoose III, vice‑président exécutif de Citizens & Northern Corp (CZNC), a déclaré des opérations sur les actions ordinaires de la société. Le 20/08/2025, une acquisition exonérée a eu lieu via le plan ESOP de la société par réinvestissement des dividendes, résultant en 221 actions acquises à 19,63 $, portant la participation indirecte de M. Hoose à 15 718 actions. Par ailleurs, 39 321 actions ont été cédées (le formulaire indique le montant cédé). Le dépôt a été signé par un mandataire le 25/08/2025. Le formulaire précise que la transaction visait, le cas échéant, à bénéficier d'une défense affirmative en vertu de la règle 10b5-1 et identifie le déclarant comme dirigeant (VICE‑PRÉSIDENT EXÉCUTIF) et administrateur.
Harold F. Hoose III, Executive Vice President von Citizens & Northern Corp (CZNC), meldete Transaktionen mit Stammaktien des Unternehmens. Am 20.08.2025 erfolgte ein befreiter Erwerb über den ESOP des Unternehmens durch Reinvestition von Dividenden, wobei 221 Aktien zu $19,63 erworben wurden und Herrn Hooses indirekter wirtschaftlicher Besitz damit 15.718 Aktien beträgt. Separat wurden 39.321 Aktien veräußert (die Veräußerungsmenge ist im Formular vermerkt). Die Einreichung wurde am 25.08.2025 von einem Bevollmächtigten unterschrieben. Das Formular weist darauf hin, dass die Transaktion, soweit anwendbar, dazu bestimmt war, für eine affirmative Verteidigung gemäß Regel 10b5-1 in Frage zu kommen, und benennt die meldende Person als leitenden Angestellten (EXEC. VP) und Direktor.
- ESOP acquisition of 221 shares was disclosed as exempt via dividend reinvestment, indicating routine plan activity
- Form 4 properly identifies the reporting person as Executive Vice President and director and includes a signature via attorney-in-fact
- Material disposition of 39,321 shares is reported without price or transaction-code detail, reducing transparency
- Filing does not provide context for the disposal (e.g., whether part of a planned sale or transfer), limiting investor assessment
Insights
TL;DR: Routine insider ESOP reinvestment acquisition and a large reported disposition create a neutral disclosure with limited immediate market impact.
The Form 4 shows an exempt ESOP acquisition of 221 shares at $19.63 via dividend reinvestment, increasing indirect holdings to 15,718 shares. The form also reports a disposal of 39,321 shares but does not provide execution details linking that disposition to any specific sale program or price. For investors, the ESOP reinvestment is administrative and customary; the materiality of the 39,321-share disposition depends on context not present in the filing (such as percentage of outstanding shares or timing/pricing). Because the filing lacks price/details for the disposal and broader context, its informative value for valuation or governance analysis is limited.
TL;DR: Disclosure is compliant and indicates officer-level activity, but missing disposal details reduce transparency.
The report properly identifies the reporting person, relationship to the issuer, and the exempt nature of the ESOP acquisition. Signature by an attorney-in-fact is noted. However, the filing records a significant disposal quantity (39,321 shares) without accompanying transaction codes or prices for that disposal line, limiting stakeholders' ability to assess motives or compliance with insider trading policies. From a governance perspective, further detail would improve transparency.
Harold F. Hoose III, Vicepresidente esecutivo di Citizens & Northern Corp (CZNC), ha comunicato operazioni sul titolo ordinario della società. Il 20/08/2025 si è verificato un acquisto esentato attraverso il piano ESOP della società mediante reinvestimento dei dividendi, con 221 azioni acquisite a $19,63, portando la partecipazione indiretta del Sig. Hoose a 15.718 azioni. Separatamente, sono state cedute 39.321 azioni (l'importo della cessione risulta nel modulo). La comunicazione è stata firmata per procura il 25/08/2025. Il modulo specifica che la transazione mirava a rientrare in una difesa affermativa ai sensi della Rule 10b5-1, ove applicabile, e indica la persona che effettua la segnalazione come dirigente (VICEPRESIDENTE ESECUTIVO) e amministratore.
Harold F. Hoose III, vicepresidente ejecutivo de Citizens & Northern Corp (CZNC), informó operaciones con acciones ordinarias de la compañía. El 20/08/2025 se produjo una adquisición exenta a través del ESOP de la empresa mediante el reinversión de dividendos, resultando en 221 acciones adquiridas a $19.63, elevando la propiedad indirecta del Sr. Hoose a 15.718 acciones. De forma separada, se dispusieron 39.321 acciones (el formulario registra la cantidad dispuesta). El documento fue firmado por apoderado el 25/08/2025. El formulario indica que la transacción estaba destinada a calificar para una defensa afirmativa bajo la Regla 10b5-1 cuando corresponda e identifica a la persona informante como ejecutivo (VICEPRESIDENTE EJECUTIVO) y director.
Harold F. Hoose III, Citizens & Northern Corp(CZNC)의 전무 부사장이 회사 보통주 거래를 신고했습니다. 2025년 8월 20일 배당금 재투자를 통한 회사의 ESOP 경로로 면제 취득이 이루어져 주당 $19.63에 221주를 취득했고, 이로써 Hoose 씨의 간접적 실질보유주식은 15,718주가 되었습니다. 별도로 39,321주가 처분되었습니다(서류에 처분 수량이 기재됨). 신고서는 2025년 8월 25일 대리인이 서명했습니다. 양식은 해당되는 경우 Rule 10b5-1에 따른 적극적 방어(affirmative defense) 자격을 목적으로 한 거래였음을 명시하며, 신고인을 임원(전무 부사장) 겸 이사로 표시하고 있습니다.
Harold F. Hoose III, vice‑président exécutif de Citizens & Northern Corp (CZNC), a déclaré des opérations sur les actions ordinaires de la société. Le 20/08/2025, une acquisition exonérée a eu lieu via le plan ESOP de la société par réinvestissement des dividendes, résultant en 221 actions acquises à 19,63 $, portant la participation indirecte de M. Hoose à 15 718 actions. Par ailleurs, 39 321 actions ont été cédées (le formulaire indique le montant cédé). Le dépôt a été signé par un mandataire le 25/08/2025. Le formulaire précise que la transaction visait, le cas échéant, à bénéficier d'une défense affirmative en vertu de la règle 10b5-1 et identifie le déclarant comme dirigeant (VICE‑PRÉSIDENT EXÉCUTIF) et administrateur.
Harold F. Hoose III, Executive Vice President von Citizens & Northern Corp (CZNC), meldete Transaktionen mit Stammaktien des Unternehmens. Am 20.08.2025 erfolgte ein befreiter Erwerb über den ESOP des Unternehmens durch Reinvestition von Dividenden, wobei 221 Aktien zu $19,63 erworben wurden und Herrn Hooses indirekter wirtschaftlicher Besitz damit 15.718 Aktien beträgt. Separat wurden 39.321 Aktien veräußert (die Veräußerungsmenge ist im Formular vermerkt). Die Einreichung wurde am 25.08.2025 von einem Bevollmächtigten unterschrieben. Das Formular weist darauf hin, dass die Transaktion, soweit anwendbar, dazu bestimmt war, für eine affirmative Verteidigung gemäß Regel 10b5-1 in Frage zu kommen, und benennt die meldende Person als leitenden Angestellten (EXEC. VP) und Direktor.
FAQ
What transactions did Harold F. Hoose III report on Form 4 for CZNC?
How many CZNC shares does Harold F. Hoose III beneficially own after the reported transaction?
Was the acquisition for CZNC exempt and how was it executed?
Who signed the Form 4 for Harold F. Hoose III?
Does the Form 4 explain the reason for the 39,321-share disposition?
